Master Atorvastatin (Lipitor) with Picmonic for Nursing RN

With Picmonic, facts become pictures. We've taken what the science shows - image mnemonics work - but we've boosted the effectiveness by building and associating memorable characters, interesting audio stories, and built-in quizzing.

DOWNLOAD PDF

Recommended Picmonics

Bile Acid Resins

Gemfibrozil (Fibrates)

Ezetimibe

Fibrates

Atorvastatin (Lipitor)

A-tofu-statue

Picmonic

Atorvastatin is an HMG-CoA reductase inhibitor and belongs to the statin class of medications. These medications end with the suffix “-statin” and are relatively similar. Statins inhibit the enzyme HMG-CoA reductase, which normally catalyzes the rate-limiting step in cholesterol biosynthesis. Inhibition of this enzyme results in reduction of levels of bad cholesterol (LDL) and triglycerides and increasing levels of good cholesterol (HDL). Statins are indicated in the treatment of hypercholesterolemia. Side effects can include rash, hepatotoxicity, and myopathy potentially leading to rhabdomyolysis. Therefore, it is recommended that liver enzymes be monitored at onset of therapy and repeated if signs of liver damage develop. HMG-CoA reductase inhibitors should be taken at bedtime and grapefruit juice should be avoided, as the latter can interfere with statin metabolism via the cytochrome P450 enzyme pathway.

10 KEY FACTS

Drugs in this class end with the “statin” suffix and generally have a similar mechanism of action and effect.

Statins inhibit the enzyme HMG-CoA reductase, which normally catalyzes the rate-limiting step in cholesterol biosynthesis. HMG-CoA reductase inhibitors are effective at decreasing low-density lipoprotein (LDL) and total cholesterol levels. Further, this class may increase the “good cholesterol”, referred to as high-density lipoprotein (HDL) and decrease triglycerides. This mechanism has been found to decrease the risk of heart disease and sudden death.

HMG-CoA reductase inhibitors are indicated for the treatment of high cholesterol levels (hypercholesterolemia). This class of medications decreases the “bad cholesterol” (low density lipoprotein, LDL) and triglycerides, while simultaneously increasing the “good cholesterol” (high density lipoprotein, HDL), although the effects on HDL are a little more variable.

Hepatotoxicity may occur in patients receiving statin medications. The liver is responsible for the production of cholesterol; therefore, these medications may cause injury to hepatocytes. If signs or symptoms of liver injury such as jaundice develop, liver function tests should be performed.

One of the side effects of statins is the development of a rash.

Rhabdomyolysis, or the breakdown of muscle cells, can occur with statin use. Statins can damage myocytes and lead to myopathy. If this persists, rhabdomyolysis can occur as damaged cells release myoglobin into the bloodstream. This myoglobin is filtered into the kidneys and broken down into heme pigment. Heme pigment is toxic to the kidneys and results in acute kidney injury (AKI). A mainstay of treatment is judicious IV hydration.

Myopathy, or injury to muscle tissue, may occur with use of high-dose statins. Patients receiving statin therapy should be monitored for diffuse or local muscle aches, weakness, and tenderness. Creatinine kinase (CK) levels in the serum can be checked to assess for muscle cell damage in myositis or the more severe problem of rhabdomyolysis.

Because statins may cause liver damage, liver enzymes should be checked before starting this medication, and repeated if clinical concern for liver damage arises.

The liver produces the majority of cholesterol at night time. For this reason it is recommended that statins are administered at bedtime.

Grapefruits and their juice should be avoided in patients taking statins because grapefruits contain chemicals that inhibit the enzyme CYP3A4, causing levels of the statin to rise.

DOWNLOAD PDF